A detailed history of T. Rowe Price Investment Management, Inc. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,926,767 shares of AVNS stock, worth $37 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,926,767
Previous 1,855,868 3.82%
Holding current value
$37 Million
Previous $41.6 Million 7.85%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.97 - $22.68 $1.27 Million - $1.61 Million
70,899 Added 3.82%
1,926,767 $38.4 Million
Q4 2023

Feb 14, 2024

BUY
$17.64 - $22.99 $4.04 Million - $5.26 Million
228,785 Added 14.06%
1,855,868 $41.6 Million
Q3 2023

Nov 14, 2023

BUY
$19.93 - $26.31 $2.35 Million - $3.1 Million
117,901 Added 7.81%
1,627,083 $32.9 Million
Q2 2023

Aug 14, 2023

BUY
$22.53 - $30.98 $6.09 Million - $8.38 Million
270,471 Added 21.83%
1,509,182 $38.6 Million
Q1 2023

May 15, 2023

BUY
$26.92 - $31.75 $33.3 Million - $39.3 Million
1,238,711 New
1,238,711 $36.8 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $893M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.